plerixafor has been researched along with adenine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annaert, P; Augustijns, P; Bridger, G; De Clercq, E; Henson, G; Kinget, R; Naesens, L; Pannecouque, C; Shafiee, M; Van den Mooter, G; Van Gelder, J; Witvrouw, M | 1 |
| De Clercq, E | 1 |
| Buggins, AG; Devereux, S; Fegan, C; Forconi, F; Jones, CH; Pepper, C; Pratt, G; Stevenson, FK; Walsby, EJ | 1 |
1 review(s) available for plerixafor and adenine
| Article | Year |
|---|---|
The discovery of antiviral agents: ten different compounds, ten different stories.
Topics: Acyclovir; Adenine; Antiviral Agents; Benzodiazepines; Benzylamines; Cidofovir; Cyclams; Cytosine; Heterocyclic Compounds; Humans; Imidazoles; Nucleosides; Organophosphonates; Tenofovir; Valacyclovir; Valine; Virus Diseases | 2008 |
2 other study(ies) available for plerixafor and adenine
| Article | Year |
|---|---|
Evaluation of the potential of ion pair formation to improve the oral absorption of two potent antiviral compounds, AMD3100 and PMPA.
Topics: Adenine; Animals; Anti-HIV Agents; Benzylamines; Caco-2 Cells; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Cyclams; Epithelium; Heterocyclic Compounds; Humans; Octanols; Organophosphonates; Organophosphorus Compounds; Rabbits; Solubility; Taurocholic Acid; Tenofovir | 1999 |
Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzylamines; Chemokine CXCL12; Class I Phosphatidylinositol 3-Kinases; Cyclams; Gene Expression Regulation, Neoplastic; Genetic Heterogeneity; Heterocyclic Compounds; Humans; Immunoglobulin Heavy Chains; Integrin alpha4; Leukemia, Lymphocytic, Chronic, B-Cell; Mutation; Natalizumab; Piperidines; Prognosis; Protein-Tyrosine Kinases; Purines; Pyrazoles; Pyrimidines; Quinazolinones; Receptors, CXCR4; Signal Transduction; Survival Analysis | 2015 |